E-mail a Friend

Cerebrovascular Initiative

The University of Miami Cerebrovascular Initiative (UMCVI) provides world-class care to patients afflicted with complex cerebrovascular diseases including the use of minimally invasive and endoscopic approaches for brain tumors. UMCVI doctors use their expertise in endovascular procedures to provide brain tumor embolization (the endovascular delivery of blood vessel clogging agents to reduce the tumors blood supply), and intra-arterial delivery of chemotherapeutic agents directly to the tumor for management of both operable and inoperable tumors. Dr. Peterson, director of endovascular neurosurgery, has extensive expertise in the intra-arterial delivery of chemotherapy to the eye for the treatment of retinoblastoma. Dr. Peterson has performed over 200 of these delicate and specialized procedures. Dr. Starke, co-director of endovascular neurosurgery and director of neurovascular research, has expertise in all aspects of brain tumor surgery and has a busy brain tumor practice, with approximately 1/3 of his patients being referred to him for brain tumors.

The UMCVI strives to lead the nation in both the treatment and cutting edge research of neurovascular diseases and brain tumors, and in the education and training of fellows, residents, and scientists. The UMCVI is committed to the “bench to bedside” translation of research and is therefore active in clinical, translational, and basic science research.

UMCVI Research Interests

Dr. Starke and Dr. Peterson lead an active endovascular laboratory where they are involved in researching novel methods for the treatment of stroke, aneurysms, arteriovenous malformations as well as the embolization and endovascular administration of chemotherapy for tumors.

Basic Research

The basic science research of the UMCVI is focused upon investigating the formation, progression, and rupture of aneurysms. The ultimate goal of this research is to define new medications which may allow for the management of aneurysms without the need for surgical intervention. Experiments are also being conducted to determine the potential of stem cell based therapies to improve the healing of blood vessels following injury and treatment.

Translational Research

Access to highly sophisticated imaging equipment, such as biplane angiography, CT and MRI, allows the UMCVI to lead through innovations with novel cellular, medical, radiographic, surgical, and endovascular techniques. We have recently designed new stents that are able to deliver both stem cells and medications to the site of vascular repair.

Clinical Research

The UMCVI is actively involved many clinical trials and studies ranging from novel micro-delivery stent systems, and vascular reconstruction devices, to retrospective studies for stroke, cerebral aneurysms, retinoblastoma, and cancer treatments to name a few.

Robert M. Starke, MD
Director of Neurovascular Research
Co-Director of Endovascular Neurosurgery JMH
Assistant Professor of Clinical Neurosurgery
Assistant Professor of Clinical Radiology
Miami Miller School of Medicine
Miami University Hospital
Miami Children’s Hospital
Jackson Memorial Hospital
RStarke@med.miami.edu

Eric Peterson, MD
Assistant Professor of Neurological Surgery
Co-Director of Endovascular Neurosurgery
Director of Endovascular Fellowship, Nicklaus Children Hospital
Director of Endovascular Neurosurgery, University of Miami Hospital
Executive Stroke Council Board Member at the University of Miami
EricPete@med.miami.edu

John W.Thompson, PhD
Director of Basic Science Research
JThompson@med.miami.edu
Office: 305.243.3806
Fax: 305.243.3337
UMCVI’s official website

E-mail a Friend